Braveheart Bio, Inc. ($BRVE)
Filing Information
| Accession Number | 0000947871-26-000782 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
51,072,420
Total Value
$34,920,000.00
P&L
+38.9% (+$13,599,400.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 7, 2026 | Conversion | 9,132,420 | โ | โ | 10,235,159 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Purchase | 1,666,667 | $18.00 | $30,000,006.00 | 11,901,826 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Purchase | 273,333 | $18.00 | $4,919,994.00 | 273,333 | Indirect | See footnotes | View Details | |
Director | Series A Preferred Stock | Derivative | Aug 7, 2026 | Conversion | 40,000,000 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details |